Qiagen N.V./ NL0015001WM6 /
| 15/05/2024 10:09:07 | Var. +0.3950 | Volume | Denaro14:34:36 | Lettera14:34:36 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
|---|---|---|---|---|---|---|---|
| 42.0400EUR | +0.95% | 120 Fatturato: 5,044.8000 |
42.0350Quantità in denaro: 340 | 42.0650Quantità in lettera: 340 | 9.56 bill.EUR | - | - |
GlobeNewswire
14:32
Kartoon Studios Continues Execution of Growth Strategy With Profitability Targeted for Q2 2025; Prov...
GlobeNewswire
14:31
The Real Good Food Company to Participate in the 24th Annual B. Riley Institutional Investor Confere...
GlobeNewswire
14:30
Zhibao Technology Inc. Announces Closing of Underwriters’ Over-Allotment Option in Connection with I...
GlobeNewswire
14:30
Hudson Technologies to Attend 24th Annual B. Riley Securities Institutional Investor Conference
GlobeNewswire
14:30
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic C-Store Plans in Los Angeles with 7-Eleven
GlobeNewswire
14:30
Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights fo...
GlobeNewswire
14:30
Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the A...
GlobeNewswire
14:30
Reliance Global Group Announces Game-Changing Acquisition of Spetner Associates; Projected to Double...
GlobeNewswire
14:30
ALERUS FINANCIAL CORPORATION AND HMN FINANCIAL, INC. JOINTLY ANNOUNCE STRATEGIC TRANSACTION
GlobeNewswire
14:30
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
14:30
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
GlobeNewswire
14:30
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
14:30
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Tria...
GlobeNewswire
14:30
Leaders in Data Strategy Gather at Qlik Connect 2024 to Showcase AI Innovation and Results
